SWKS
59
-3
QCOM
84
2
LEG
28
4
HP
33
3
MPC
44
2
BXP
46
2
AME
62
2
RL
76
-2
OKE
62
6
M
27
2
VZ
24
5
PRGO
36
-3
APH
73
2
BF.B
48
-3
MCO
78
4
VFC
40
-2
PLD
61
-2
SLB
44
5
V
64
6
GOOG
73
-8
SWKS
59
-3
QCOM
84
2
LEG
28
4
HP
33
3
MPC
44
2
BXP
46
2
AME
62
2
RL
76
-2
OKE
62
6
M
27
2
VZ
24
5
PRGO
36
-3
APH
73
2
BF.B
48
-3
MCO
78
4
VFC
40
-2
PLD
61
-2
SLB
44
5
V
64
6
GOOG
73
-8
Financhill
Back

Cadence Bank Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
74

CADE
Cadence Bank

Last Price:
27.32
Seasonality Move:
-0.2%
Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
37.44
Seasonality Move:
3.65%
Buy
74
Cadence Bank (CADE) is a Buy

Is Cadence Bank a Buy, Sell or Hold?

  • The current Cadence Bank [CADE] share price is $27.33. The Score for CADE is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • CADE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CADE Stock Price Chart

What is Cadence Bank's stock price today?

  • The Cadence Bank share price today is $27.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CADE is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $37.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

CADE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 42.32 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.53 - 28.99) Sell
Bollinger Bands (100): (26.85 - 28.85) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 37.74 Sell
Chaikin Money Flow: -836354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.26 - 42.36) Sell
Bollinger Bands (100): (41.26 - 48.86) Sell

CADE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.59 Sell
20-day SMA: 27.98 Sell
50-day SMA: 28.21 Sell
200-day SMA: 26.22 Buy
8-day EMA: 27.55 Sell
20-day EMA: 27.93 Sell
50-day EMA: 28.1 Sell
200-day EMA: 26.72 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.11 Sell
20-day SMA: 40.61 Sell
50-day SMA: 42.43 Sell
200-day SMA: 42.45 Sell
8-day EMA: 40.32 Sell
20-day EMA: 40.92 Sell
50-day EMA: 42.29 Sell
200-day EMA: 43.55 Sell

Cadence Bank Earnings Growth & CADE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.06 per share, an increase this year of $0.11 per share, and an increase next year of $0.30 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Cadence Bank Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):